HETEROGENEITY OF EGFRvIII-POSITIVE GLIOBLASTOMA STEM CELLS: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT
Publication
, Conference
Kwatra, M; Nanni, C; Roberts, C; Kwatra, S; Lesser, GJ; Gilbert, MR
Published in: NEURO-ONCOLOGY
November 1, 2017
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2017
Volume
19
Start / End Page
55 / 55
Location
San Francisco, CA
Publisher
OXFORD UNIV PRESS INC
Conference Name
Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kwatra, M., Nanni, C., Roberts, C., Kwatra, S., Lesser, G. J., & Gilbert, M. R. (2017). HETEROGENEITY OF EGFRvIII-POSITIVE GLIOBLASTOMA STEM CELLS: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT. In NEURO-ONCOLOGY (Vol. 19, pp. 55–55). San Francisco, CA: OXFORD UNIV PRESS INC.
Kwatra, Madan, Cory Nanni, Callie Roberts, Shawn Kwatra, Glenn J. Lesser, and Mark R. Gilbert. “HETEROGENEITY OF EGFRvIII-POSITIVE GLIOBLASTOMA STEM CELLS: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT.” In NEURO-ONCOLOGY, 19:55–55. OXFORD UNIV PRESS INC, 2017.
Kwatra M, Nanni C, Roberts C, Kwatra S, Lesser GJ, Gilbert MR. HETEROGENEITY OF EGFRvIII-POSITIVE GLIOBLASTOMA STEM CELLS: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT. In: NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2017. p. 55–55.
Kwatra, Madan, et al. “HETEROGENEITY OF EGFRvIII-POSITIVE GLIOBLASTOMA STEM CELLS: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT.” NEURO-ONCOLOGY, vol. 19, OXFORD UNIV PRESS INC, 2017, pp. 55–55.
Kwatra M, Nanni C, Roberts C, Kwatra S, Lesser GJ, Gilbert MR. HETEROGENEITY OF EGFRvIII-POSITIVE GLIOBLASTOMA STEM CELLS: IMPLICATIONS FOR PERSONALIZED DRUG DEVELOPMENT. NEURO-ONCOLOGY. OXFORD UNIV PRESS INC; 2017. p. 55–55.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
November 1, 2017
Volume
19
Start / End Page
55 / 55
Location
San Francisco, CA
Publisher
OXFORD UNIV PRESS INC
Conference Name
Joint Conference of 22nd Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology / Conference of the Society-for-CNS-Interstitial-Delivery-of-the-Therapeutics (SCIDOT) on Therapeutic Delivery to the CNS
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences